StocksAstraZeneca PLC ADRAZN

AZN

AstraZeneca PLC ADR

54.76 -0.65 (-1.17%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
54.73
B
54.84

Overview

Prev Close54.76
Day's Range53.58 - 54.73
52 Week Range46.44 - 64.14
Average Volume (3m)5.37M
1-Year Return0.07%
Beta0.5861
Market Cap169.66B
P/E Ratio85.83
Revenue34.41B
EPS0.638
Dividend (Yield)1.37 (2.50%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.724/06/202107/09/202117/11/202156.0058.0060.0062.0064.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Pascal Soriot, MBA, DVM
Employees 76,100

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2020: AstraZeneca PLC ADR's revenues increased by 8.45% and amounted to 27.81B. Net income increased by 157.16% to 3.17B. Net assets increased by 7.14% to 15.64B and EPS increased from 0.52 to 1.23.
AZN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
66.08%
Net Profit Margin
11.08%
Operating Margin
12.45%
Return On Investment
8.61%
12/20
03/21
06/21
09/21
Total Revenue
7.99B
7.35B
8.2B
9.87B
Gross Profit
6.02B
5.48B
6.02B
5.03B
Operating Income
1.48B
767.65M
1.07B
-100M
Net Income
1.01B
1.57B
548.93M
-1.65B